AKBA sells 9.78M* shares @10.50—a 12.5% discount to yesterday’s close—and a 28% discont to AKBA's previous financing 9 months ago: https://finance.yahoo.com/news/akebia-therapeutics-announces-pricing-public-120000597.html *Assuming exercise of underwriter’s option.